Global Allergy Immunotherapy Market (2018-2022 Edition)
Scope of the Report
The report titled “Global Allergy Immunotherapy Market (2018-2022 Edition)”, provides an in-depth analysis of the global allergy immunotherapy market by value, by methods of administration, by region, etc. The report provides a regional analysis of the allergy immunotherapy market, including the following regions: the US, Europe and Rest of the World.
Growth of the overall global allergy immunotherapy market has also been forecasted for the period 2018-2022, taking into consideration the previous growth patterns, the growth drivers and the current and future trends.
The key players of the allergy immunotherapy market ALK-Abello, Allergy Therapeutics, Merck Group and Stallergenes, who are also profiled with their financial information and respective business strategies.
Country Coverage
Allergen immunotherapy, also known as “allergy shots”, is a form of long-term treatment that decreases symptoms for many people with allergic rhinitis, allergic asthma, conjunctivitis (eye allergy) or stinging insect allergy. Immunotherapy involves exposing people to larger and larger amounts of allergen in an affect to change the immune system's response. Allergy immunotherapy is an established treatment for severe allergies such as allergic rhinitis and allergic asthma. The allergy immunotherapy can be classified on the basis of method of administration: subcutaneous (SCIT), sublingual (SLIT-tablets/drops) and whole allergen.
The global allergy immunotherapy market has increased at a significant CAGR during the years 2013-2017 and projections are made that the market would rise in the next four years i.e. 2018-2022 tremendously. The allergy immunotherapy market is expected to increase due to growth in healthcare expenditure, rising incidence of chronic diseases and increasing global pollution, etc. Yet the market faces some challenges such as, lack of treatment awareness, lack of investor confidence, anaphylaxia, huge treatment costs, etc.
The report titled “Global Allergy Immunotherapy Market (2018-2022 Edition)”, provides an in-depth analysis of the global allergy immunotherapy market by value, by methods of administration, by region, etc. The report provides a regional analysis of the allergy immunotherapy market, including the following regions: the US, Europe and Rest of the World.
Growth of the overall global allergy immunotherapy market has also been forecasted for the period 2018-2022, taking into consideration the previous growth patterns, the growth drivers and the current and future trends.
The key players of the allergy immunotherapy market ALK-Abello, Allergy Therapeutics, Merck Group and Stallergenes, who are also profiled with their financial information and respective business strategies.
Country Coverage
- The US
- Europe
- Rest of the World
- ALK-Abello
- Allergy Therapeutics
- Merck Group
- Stallergenes
Allergen immunotherapy, also known as “allergy shots”, is a form of long-term treatment that decreases symptoms for many people with allergic rhinitis, allergic asthma, conjunctivitis (eye allergy) or stinging insect allergy. Immunotherapy involves exposing people to larger and larger amounts of allergen in an affect to change the immune system's response. Allergy immunotherapy is an established treatment for severe allergies such as allergic rhinitis and allergic asthma. The allergy immunotherapy can be classified on the basis of method of administration: subcutaneous (SCIT), sublingual (SLIT-tablets/drops) and whole allergen.
The global allergy immunotherapy market has increased at a significant CAGR during the years 2013-2017 and projections are made that the market would rise in the next four years i.e. 2018-2022 tremendously. The allergy immunotherapy market is expected to increase due to growth in healthcare expenditure, rising incidence of chronic diseases and increasing global pollution, etc. Yet the market faces some challenges such as, lack of treatment awareness, lack of investor confidence, anaphylaxia, huge treatment costs, etc.
1. EXECUTIVE SUMMARY
2. INTRODUCTION
2.1 Allergy
2.2 History of Allergy
2.3 Diagnosis of Allergy
2.4 Nature of Allergy
2.5 Types of Allergy by Allergens
2.6 Types of Allergens
2.7 Prevention of Allergies
2.8 Allergy Immunotherapy: An Overview
2.8.1 Types of Immunotherapy
2.8.2 Mechanism of Immunotherapy
2.8.3 Immunotherapy by Methods of Administration
3. GLOBAL MARKET ANALYSIS
3.1 Global Allergy Immunotherapy Market: An Analysis
3.1.1 Global Allergy Immunotherapy Market by Value
3.1.2 Global Allergy Immunotherapy Market by Geography
3.1.3 Global Allergy Immunotherapy Market Share (Regional) by Patients
3.1.4 Global Allergy Immunotherapy Market by Method of Administration (SCIT, SLIT Tablets, SLIT Drops)
3.2 Global Allergy Immunotherapy Market: Methods of Administration Analysis
3.2.1 Global Subcutaneous Immunotherapy Market by Value
3.2.2 Global Sublingual Immunotherapy Solution Market by Value
3.2.3 Global Sublingual Immunotherapy-Tablet Market by Value
4. REGIONAL MARKET ANALYSIS
4.1 Europe Allergy Immunotherapy Market: An Analysis
4.1.1 Europe Allergy Immunotherapy Market by Value
4.1.2 Europe Allergy Immunotherapy Market by Method of Administration
4.1.3 Europe Allergy Immunotherapy Market by Common Allergies
4.1.4 Europe Allergy Immunotherapy Market by Regional Distribution
4.2 The US Allergy Immunotherapy Market: An Analysis
4.2.1 The US Allergy Immunotherapy Market by Value
4.2.2 The US Allergy Immunotherapy Market by Method of Administration
4.3 Rest of the World Allergy Immunotherapy Market: An Analysis
4.3.1 Rest of the World Allergy Immunotherapy Market by Value
5. COMPETITIVE LANDSCAPE
5.1 Global Competitive Landscape
5.1.1 Global Allergy Immunotherapy Market Players by Share
5.2 Regional Competitive Landscape
5.2.1 Europe Allergy Immunotherapy Market Players by Share
5.2.2 US Allergy Immunotherapy Market Players by Share
6. COMPANY PROFILE
6.1 Allergy Therapeutics plc.
6.1.1 Business Overview
6.1.2 Financial Overview
6.1.3 Business Strategy
6.2 ALK-Abello
6.2.1 Business Overview
6.2.2 Financial Overview
6.2.3 Business Strategy
6.3 Merck Group
6.3.1 Business Overview
6.3.2 Financial Overview
6.3.3 Business Strategy
6.4 Stallergenes
6.4.1 Business Overview
6.4.2 Financial Overview
6.4.3 Business Strategy
2. INTRODUCTION
2.1 Allergy
2.2 History of Allergy
2.3 Diagnosis of Allergy
2.4 Nature of Allergy
2.5 Types of Allergy by Allergens
2.6 Types of Allergens
2.7 Prevention of Allergies
2.8 Allergy Immunotherapy: An Overview
2.8.1 Types of Immunotherapy
2.8.2 Mechanism of Immunotherapy
2.8.3 Immunotherapy by Methods of Administration
3. GLOBAL MARKET ANALYSIS
3.1 Global Allergy Immunotherapy Market: An Analysis
3.1.1 Global Allergy Immunotherapy Market by Value
3.1.2 Global Allergy Immunotherapy Market by Geography
3.1.3 Global Allergy Immunotherapy Market Share (Regional) by Patients
3.1.4 Global Allergy Immunotherapy Market by Method of Administration (SCIT, SLIT Tablets, SLIT Drops)
3.2 Global Allergy Immunotherapy Market: Methods of Administration Analysis
3.2.1 Global Subcutaneous Immunotherapy Market by Value
3.2.2 Global Sublingual Immunotherapy Solution Market by Value
3.2.3 Global Sublingual Immunotherapy-Tablet Market by Value
4. REGIONAL MARKET ANALYSIS
4.1 Europe Allergy Immunotherapy Market: An Analysis
4.1.1 Europe Allergy Immunotherapy Market by Value
4.1.2 Europe Allergy Immunotherapy Market by Method of Administration
4.1.3 Europe Allergy Immunotherapy Market by Common Allergies
4.1.4 Europe Allergy Immunotherapy Market by Regional Distribution
4.2 The US Allergy Immunotherapy Market: An Analysis
4.2.1 The US Allergy Immunotherapy Market by Value
4.2.2 The US Allergy Immunotherapy Market by Method of Administration
4.3 Rest of the World Allergy Immunotherapy Market: An Analysis
4.3.1 Rest of the World Allergy Immunotherapy Market by Value
5. COMPETITIVE LANDSCAPE
5.1 Global Competitive Landscape
5.1.1 Global Allergy Immunotherapy Market Players by Share
5.2 Regional Competitive Landscape
5.2.1 Europe Allergy Immunotherapy Market Players by Share
5.2.2 US Allergy Immunotherapy Market Players by Share
6. COMPANY PROFILE
6.1 Allergy Therapeutics plc.
6.1.1 Business Overview
6.1.2 Financial Overview
6.1.3 Business Strategy
6.2 ALK-Abello
6.2.1 Business Overview
6.2.2 Financial Overview
6.2.3 Business Strategy
6.3 Merck Group
6.3.1 Business Overview
6.3.2 Financial Overview
6.3.3 Business Strategy
6.4 Stallergenes
6.4.1 Business Overview
6.4.2 Financial Overview
6.4.3 Business Strategy
LIST OF FIGURES
Figure 1: Mechanism of Allergy
Figure 2: Diagnosis of Allergy
Figure 3: Nature of Allergy
Figure 4: Types of Allergy
Figure 5: Types of Allergens
Figure 6: Types of Immunotherapy
Figure 7: Immunotherapy by Methods of Administration
Figure 8: Global Allergy Immunotherapy Market by Value; 2013-2017 (US$ Billion)
Figure 9: Global Allergy Immunotherapy Market by Value; 2018-2022 (US$ Billion)
Figure 10: Global Allergy Immunotherapy Market by Geography; 2017 (Percentage,%)
Figure 11: Global Allergy Immunotherapy Market Share (Regional) by Patients; 2016 (Percentage,%)
Figure 12: Global Allergy Immunotherapy Market by Method of Administration; 2016 (Percentage,%)
Figure 13: Global Subcutaneous Allergy Immunotherapy Market by Value; 2013-2017 (US$ Million)
Figure 14: Global Subcutaneous Allergy Immunotherapy Market by Value; 2018-2022 (US$ Million)
Figure 15: Global Sublingual Allergy Immunotherapy Solution Market by Value; 2013-2017 (US$ Million)
Figure 16: Global Sublingual Allergy Immunotherapy Solution Market by Value; 2018-2022 (US$ Million)
Figure 17: Global Sublingual Allergy Immunotherapy-Tablet Market by Value; 2013-2017 (US$ Million)
Figure 18: Global Sublingual Allergy Immunotherapy-Tablet Market by Value; 2018-2022 (US$ Million)
Figure 19: Europe Allergy Immunotherapy Market by Value; 2013-2017 (US$ Million)
Figure 20: Europe Allergy Immunotherapy Market by Method of Administration; 2016 (Percentage,%)
Figure 21: Europe Allergy Immunotherapy Market by Common Allergies; 2016 (Percentage,%)
Figure 22: Europe Allergy Immunotherapy Market by Regional Distribution; 2016 (Percentage,%)
Figure 23: The US Allergy Immunotherapy Market by Value; 2013-2017 (US$ Million)
Figure 24: The US Allergy Immunotherapy Market by Method of Administration; 2016
Figure 25: Rest of the World Allergy Immunotherapy Market by Value; 2013-2017 (US$ Million)
Figure 26: Global Allergy Immunotherapy Market Players by Share; 2017(Percentage,%)
Figure 27: Europe Allergy Immunotherapy Market Players by Share; 2016 (Percentage,%)
Figure 28: The US Allergy Immunotherapy Market Players by Share; 2016 (Percentage,%)
Figure 29: Allergy Therapeutics Sales; 2013-2017 (US$ Million)
Figure 30: Allergy Therapeutics Sales by Products; 2017
Figure 31: Allergy Therapeutics Sales by Country; 2017
Figure 32: ALK-Abello Revenue; 2013-2017 (US$ Million)
Figure 33: ALK-Abello Revenue by Product Line; 2017 (Percentage,%)
Figure 34: ALK-Abello Revenue by Region; 2017 (Percentage,%)
Figure 35: Merck Group Net Sales; 2012-2016 (US$ Billion)
Figure 36: Merck Group Net Sales by Segments; 2017 (Percentage,%)
Figure 37: Merck Group Net Sales by Region; 2017 (Percentage,%)
Figure 38: Stallergenes Product Portfolio
Figure 39: Stallergenes Greer Net Sales; 2013-2017 (US$ Million)
Figure 40: Stallergenes Greer Net Sales by Segments; 2017 (Percentage,%)
Figure 41: Stallergenes Greer Net Sales by Region; 2017 (Percentage,%)
Figure 1: Mechanism of Allergy
Figure 2: Diagnosis of Allergy
Figure 3: Nature of Allergy
Figure 4: Types of Allergy
Figure 5: Types of Allergens
Figure 6: Types of Immunotherapy
Figure 7: Immunotherapy by Methods of Administration
Figure 8: Global Allergy Immunotherapy Market by Value; 2013-2017 (US$ Billion)
Figure 9: Global Allergy Immunotherapy Market by Value; 2018-2022 (US$ Billion)
Figure 10: Global Allergy Immunotherapy Market by Geography; 2017 (Percentage,%)
Figure 11: Global Allergy Immunotherapy Market Share (Regional) by Patients; 2016 (Percentage,%)
Figure 12: Global Allergy Immunotherapy Market by Method of Administration; 2016 (Percentage,%)
Figure 13: Global Subcutaneous Allergy Immunotherapy Market by Value; 2013-2017 (US$ Million)
Figure 14: Global Subcutaneous Allergy Immunotherapy Market by Value; 2018-2022 (US$ Million)
Figure 15: Global Sublingual Allergy Immunotherapy Solution Market by Value; 2013-2017 (US$ Million)
Figure 16: Global Sublingual Allergy Immunotherapy Solution Market by Value; 2018-2022 (US$ Million)
Figure 17: Global Sublingual Allergy Immunotherapy-Tablet Market by Value; 2013-2017 (US$ Million)
Figure 18: Global Sublingual Allergy Immunotherapy-Tablet Market by Value; 2018-2022 (US$ Million)
Figure 19: Europe Allergy Immunotherapy Market by Value; 2013-2017 (US$ Million)
Figure 20: Europe Allergy Immunotherapy Market by Method of Administration; 2016 (Percentage,%)
Figure 21: Europe Allergy Immunotherapy Market by Common Allergies; 2016 (Percentage,%)
Figure 22: Europe Allergy Immunotherapy Market by Regional Distribution; 2016 (Percentage,%)
Figure 23: The US Allergy Immunotherapy Market by Value; 2013-2017 (US$ Million)
Figure 24: The US Allergy Immunotherapy Market by Method of Administration; 2016
Figure 25: Rest of the World Allergy Immunotherapy Market by Value; 2013-2017 (US$ Million)
Figure 26: Global Allergy Immunotherapy Market Players by Share; 2017(Percentage,%)
Figure 27: Europe Allergy Immunotherapy Market Players by Share; 2016 (Percentage,%)
Figure 28: The US Allergy Immunotherapy Market Players by Share; 2016 (Percentage,%)
Figure 29: Allergy Therapeutics Sales; 2013-2017 (US$ Million)
Figure 30: Allergy Therapeutics Sales by Products; 2017
Figure 31: Allergy Therapeutics Sales by Country; 2017
Figure 32: ALK-Abello Revenue; 2013-2017 (US$ Million)
Figure 33: ALK-Abello Revenue by Product Line; 2017 (Percentage,%)
Figure 34: ALK-Abello Revenue by Region; 2017 (Percentage,%)
Figure 35: Merck Group Net Sales; 2012-2016 (US$ Billion)
Figure 36: Merck Group Net Sales by Segments; 2017 (Percentage,%)
Figure 37: Merck Group Net Sales by Region; 2017 (Percentage,%)
Figure 38: Stallergenes Product Portfolio
Figure 39: Stallergenes Greer Net Sales; 2013-2017 (US$ Million)
Figure 40: Stallergenes Greer Net Sales by Segments; 2017 (Percentage,%)
Figure 41: Stallergenes Greer Net Sales by Region; 2017 (Percentage,%)
